| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 2.73M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.74M | 2.73M | -41.68K | -55.28K | -199.00K | -136.00K |
| EBITDA | -4.19M | -2.46M | -5.36M | -4.26M | -2.99M | -1.32M |
| Net Income | -3.36M | -2.66M | -4.74M | -2.44M | -3.21M | 120.26K |
Balance Sheet | ||||||
| Total Assets | 100.01M | 92.50M | 95.40M | 62.47M | 37.39M | 12.31M |
| Cash, Cash Equivalents and Short-Term Investments | 4.52M | 2.42M | 565.15K | 6.89M | 15.25M | 954.25K |
| Total Debt | 3.18M | 7.79M | 13.86M | 15.37M | 5.59M | 698.40K |
| Total Liabilities | 43.04M | 43.84M | 53.78M | 36.16M | 14.68M | 8.15M |
| Stockholders Equity | 56.96M | 48.67M | 41.63M | 26.31M | 22.71M | 4.16M |
Cash Flow | ||||||
| Free Cash Flow | -845.95K | 1.91M | -15.85M | -22.31M | -9.42M | 4.53M |
| Operating Cash Flow | 3.44M | 8.10M | 11.50M | -4.31M | -3.74M | 5.89M |
| Investing Cash Flow | 8.07M | -6.24M | -16.98M | -18.04M | -5.69M | -1.54M |
| Financing Cash Flow | -5.27M | 6.24K | -854.18K | 13.99M | 23.72M | -3.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | AU$46.70M | -2.13 | -29.24% | ― | ― | 42.65% | |
52 Neutral | AU$47.42M | 1.06 | -0.34% | ― | ― | -100.38% | |
52 Neutral | AU$79.91M | -15.76 | -16.95% | ― | ― | 76.36% | |
47 Neutral | AU$46.92M | -5.83 | -6.35% | ― | ― | 59.26% | |
42 Neutral | AU$45.93M | -15.23 | -1.33% | ― | ― | ― | |
34 Underperform | AU$53.83M | -2.56 | -0.21% | ― | ― | -61.06% |
Latrobe Magnesium Limited has released its half-year financial report for the period ended 31 December 2025, covering the consolidated activities of the company and its controlled entities. The report includes the directors’ report, financial statements, cash flow statement, changes in equity, and an independent auditor’s review, providing stakeholders with an overview of the group’s financial position and performance for the half year.
The documentation outlines the company’s profit or loss, comprehensive income, and financial position as at the end of the period, along with accompanying notes and declarations. This structured disclosure is intended to enhance transparency for investors and regulators, and forms part of the company’s ongoing compliance and corporate governance obligations under Australian reporting standards.
The most recent analyst rating on (AU:LMG) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Latrobe Magnesium Limited stock, see the AU:LMG Stock Forecast page.
Latrobe Magnesium Limited has achieved continuous production of about 20 tonnes of magnesium oxide at its Hazelwood North demonstration plant, using brown coal ash over a sustained two-week operating period. The company reports that the magnesium oxide meets required quality standards and has already been sold to a customer, marking a key validation of its proprietary process.
The stabilised plant operations, following rectification of a gas transport fan defect, have allowed Latrobe to optimise its spray roaster and demonstrate ongoing production of magnesium oxide and by-products such as char, iron oxide and agricultural lime. Management says this milestone substantially de-risks the project and positions the company to move toward magnesium metal production and eventual commercial operations, with by-product validation trials now planned for potential customers and the planned Stage 2 commercial plant.
The most recent analyst rating on (AU:LMG) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Latrobe Magnesium Limited stock, see the AU:LMG Stock Forecast page.
Latrobe Magnesium Limited has notified the market of the cessation of 3,000,000 listed options (LMGAE), which expired unexercised on 5 January 2026, having carried an exercise price of $0.10 and an original expiry date of 22 December 2025. The expiry of these options without conversion marginally reduces the company’s potential future share dilution and clarifies its capital structure for investors, but does not involve any immediate cash inflow or operational change for the business.
The most recent analyst rating on (AU:LMG) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Latrobe Magnesium Limited stock, see the AU:LMG Stock Forecast page.
Latrobe Magnesium has received a non-binding and conditional Letter of Support from Export Finance Australia, indicating potential participation in financing its planned 10,000 tonne-per-annum Stage 2 commercial magnesium plant in Victoria, alongside a previously announced non-binding Letter of Interest from the US Export-Import Bank for up to A$200 million in debt. The company plans to appoint Bechtel to complete a bankable feasibility study within nine months, is seeking A$200 million in debt and A$50 million in equity, and has already allocated 100% of the plant’s output under an offtake agreement for the US market, underscoring its role in diversifying Western supply of a critical mineral currently dominated by China and Russia and strengthening its strategic positioning in the US–Australia critical minerals partnership.
Latrobe Magnesium has received a $6.29 million research and development tax incentive from the Australian Taxation Office, which it has applied directly to reduce its debt to financier RnD Funding, cutting the outstanding balance on its R&D facility to about $2.6 million. The company expects to clear this remaining liability through the planned sale of two surplus property lots for a combined $2.8 million, while also flagging a dispute over a lease extension with RnD that remains under negotiation and has been disclosed as a contingent liability, developments that collectively improve its near‑term funding position as it advances commissioning of its magnesium demonstration plant and longer-term expansion plans.